LabGenius combines artificial intelligence, robotic automation and synthetic biology to evolve next-generation protein therapeutics.

LabGenius develops therapeutics of high value for diseases of unmet need. The company deploys machine intelligence to model the relationship between DNA sequence and protein function, while improving the predictive accuracy of these models through experimental lab data generated through its smart robotic platform.

• Industry

  • AI & Machine Learning
  • Biotechnology
  • Health + Tech

• Milestones

  • Lux investment: 2019

• Founders

  • James Field

  LUX Partners

  • Shaq Vayda

• Latest Tweets

  • Back in June, we welcomed Justin Grace to @labgeni_us as a Senior Data Scientist. A few months on, we caught up… https://t.co/t5czru38t5@labgeni_us - 10h
  • Not one to miss 👀 Catch @labgeni_us Founder and CEO, @jejfield, at this year’s @Siftedeu Summit. He will be di… https://t.co/igCEJQAeRU@labgeni_us - 01:13 PM Aug 16th
  • We're delighted to welcome Dr Michael Mullin as Head of Antibody Engineering 🚀 Joining us from GSK, Michael is an… https://t.co/64nIjM9kJl@labgeni_us - 01:16 PM Jul 22nd